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Molecular differences between cortical and trabecular bone, of relevance to
understanding the pathophysiological basis of bone diseases, can be determined only through effective isolation methods for RNA and proteins.
Here we present a TRIzol-based method, which combines bone pulverization and homogenization to extract simultaneously total RNA and
proteins from human cortical and trabecular bone from the same carrot.
RNA integrity and purity were determined as the 260/280 nm and 260/
230 nm absorbance ratios and the 28S/18S rRNA ratio. Protein integrity
and quality were evaluated by Coomassie blue staining. Reverse transcription quantitative polymerase chain reaction and immunoblotting for bonespecific genes and proteins were performed to verify the suitability of the
isolated material in downstream applications. The 260/280 nm and 260/
230 nm absorbance ratios were, on average, less than or equal to 1.8.
Bands on agarose gel were consistent with intact RNA, with mean 28S/
18S ratios of 1.68 ± 0.35 and 1.88 ± 0.10 for cortical and trabecular bone,
respectively. Band patterns after Coomassie blue staining confirmed protein
integrity. Successful gene and protein expression analysis, with relevant
differences between the two compartments, highlighted the suitability of
the material in downstream applications. The method presented here is
appropriate and effective for the study of human bone.

1. Introduction

Electronic supplementary material is available
online at https://doi.org/10.6084/m9.figshare.
c.5958885.

Nucleic acid extraction from bone, and more specifically RNA, represents a big
challenge in research [1,2]. Indeed, the study of bone biology has been hindered
by several technical issues that have limited the applicability of an expected
experimental approach and/or the reliability of the obtained results. The problems that may emerge in the study of ex vivo bone samples include: (i) the
analysis of full-thickness pieces that consist of both the cortical and the trabecular bony compartments; (ii) low-quality, low-yield, highly fragmented RNA;
(iii) separate analysis of RNA and proteins from different samples.
© 2022 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original
author and source are credited.
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2. Material and methods
2.1. Specimens
Samples were obtained from a total of 10 male and female participants aged 65 years or older, but younger than 85 years,
who were recruited from candidates undergoing elective hip
replacement surgery at the IRCCS Istituto Ortopedico
Galeazzi, Milan, Italy, and enrolled in an observational,
cross-sectional study aimed at assessing the differences in several bone parameters between subjects with (body mass index
[BMI] ≥30 kg m−2) or without (BMI <25 kg m−2) obesity.
Patients treated with drugs that could affect bone or glucose
metabolism, those with a disease known to affect bone or glucose metabolism, alcohol or tobacco users and those with bone
metastases or diseases involving the surgical site other than
osteoarthritis were excluded. During surgery, bone was harvested from the internal part of the femoral neck with a
bone curette. Bone specimens were dissected and cut into
smaller pieces with an osteotome after careful removal of the
trabecular bone with a Luer bone rongeur. At this level, the
division between the two types of bones is particularly neat;
thus, isolation of the cortical bone was performed without
any difficulties. Particular attention was paid to avoiding contamination between the cortical and trabecular bone (figure 1).
The study protocol complies with the Declaration of
Helsinki and was approved by the Ethics Committee of
the IRCCS San Raffaele Hospital ( protocol VFOWPO, no.
120/2016). All subjects provided informed consent prior to
any study procedures.

2.2. Tissue homogenization
Once the sample had been collected, any residual soft tissue
attached to the bone specimens was removed with scalpel
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Finally, the possibility of using the same surgical
sample to extract, at the same time, RNA and proteins
would be desirable as it would allow a direct comparison
of transcriptomic and proteomic information [12]. Commercially available reagents allow the implementation of these
procedures and, since protein extraction is not a trivial undertaking, the possibility of using the whole biological material,
without dividing it for different analyses, increases the RNA
yield and, thus, contributes to improving the most difficult
phase of the procedure.
To understand the mechanisms of gene and protein regulation in human bone is of pivotal importance in basic,
translational and preclinical research since the study of the
signalling pathways, the fine regulatory mechanisms and
the microenvironment is necessary to unravel molecular
alterations that take place in disease (e.g. metabolic bone diseases, osteoporosis, osteoarthritis, osteolysis, osteonecrosis)
and to eventually identify possible candidates for targeted
therapies. Consequently, a standardized method for extraction and purification of high-quality RNA species and
proteins is desirable [2]. Here, we describe a novel approach
to the study of human bone biology based on the separation
of the cortical and the trabecular compartments from the
same bone carrot and the parallel extraction, from the same
sample, of high-quality RNA and proteins that can be used
for downstream analyses.

royalsocietypublishing.org/journal/rsob

Cortical and trabecular compartments of bone are distinct in
terms of macrostructure, protein and mineral distribution/composition and exerted function. The bony function is dependent
on the existence of these two distinct compartments. The cortical
compartment consists of 70% bone and 30% vascular channels.
In contrast, in the trabecular compartment only 20% of the
volume is occupied by bone while the remaining space is
filled with marrow and fat. The surface-to-volume ratio is
much greater in the trabecular than in the cortical bone.
During ageing or in the course of disease, cortical porosity
increases, thus inducing a gain in the surface-to-volume ratio
at the expense of the strength. Trabecular bone senses
the mechanical load and transfers it to the cortical bone. Further,
trabecular bone contains less calcium and more water than the
cortical fraction. The greater exposure of trabecular bone to
bone marrow and blood flow and the greater responsiveness
to mechanical loading account for the faster turnover rate in
the trabecular compartment than in the cortical one [3]. In trabecular bone, resorption takes place along the trabecular surface
while in cortical bone it takes place through the formation of tunnels. Bone loss after menopause is faster in trabecular bone, but
as cortical bone constitutes 80% of the skeleton the absolute loss
is similar for both compartments in the first 10 years; thereafter,
the loss of cortical bone prevails [4]. Further, the two compartments have differing sensitivities to hormones and drugs [5].
Despite these relevant aspects, the great majority of studies
have focused on either trabecular bone only (especially
human studies) or whole bone (especially animal studies) [6].
In contrast to protein extraction, which is not particularly
challenging because of its quantitatively relevant presence
within the bone matrix, RNA extracted from bone is often of
low quality and has undergone some degradation owing to the
low number of cells (i.e. low content of nucleic acids) and the
high amount of mineralized matrix. A successful extraction of
high-quality nucleic acids, and particularly RNA, requires four
key steps: (i) to sufficiently reduce (to pulverize) the tissue and
to lyse the cells in order to liberate their contents, (ii) to denature
the nucleoprotein complexes, (iii) to inactivate the nucleases that
may degrade the target molecules, and (iv) to purify the target
nucleic acid species [7]. Different strategies have been adopted
to limit the degradation of RNA in bone samples; for instance,
single-step RNA extraction under near-freezing temperature
conditions [8] or homogenization with stabilizing mixtures of
guanidinium thiocyanate–phenol–chloroform [9,10]. However,
despite these and many other approaches, the yield and quality
of the extracted RNA are often below the required standards
needed to proceed further with the downstream analyses [2].
Quantification and purity assessment of RNA can be determined
spectrophotometrically by reading the optical density of the
sample at λ = 260 nm, which correlates with the concentration
of nucleic acids within the sample; λ = 280 nm, which correlates
with the concentration of proteins within the sample; and
λ = 230 nm, which gives a measure of the background and contaminants. Values above 1.8 of the 260/280 nm ratio (i.e. free of
protein contamination) and above 2.0 for the 260/230 nm ratio
(i.e. free of solvent contamination) indicate the purification of
high-quality, low-contamination or pure RNA and the possibility that it can be used in downstream enzyme-based
applications [1]. RNA integrity, instead, can be assessed by agarose gel electrophoresis and the visualization of the appropriate
resolution of the bands relative to the ribosomal subunits 28S
and 18S. An 28S/18S intensity ratio of around 2 is an index of
intact RNA [11].

trabecular
bone

and tweezers. Before freezing at −80°C, bone tissues were
washed several times in ice-chilled sterile phosphate-buffered
saline, in order to remove blood residues. As shown in figure 2,
frozen bones were ground with a pestle and mortar in liquid
nitrogen and then stored at −80°C until processing or for 1
month. Four hundred milligrams of bone, reduced to a fine
powder, were added to tubes that had been pre-chilled in
dry ice and that contained ceramic beads (Precellys Lysing
Kit, Tissue Grinding CKmix50_7 mL; Bertin Instrument,
Montigny-le-Bretonneux, France). After the addition of 4 ml
TriReagent (Ambion Inc., ThermoFisher Scientific, Waltham,
MA, USA), according to the recommended proportions (1 ml
TriReagent per 100 mg tissue), bone powder was homogenized using a Minilys Homogenizer (Bertin Instrument), at
speed 2, for 20 s, seven times. Tubes were kept in ice for
1 min between each homogenization cycle in order to allow
the sample, beads and TriReagent to chill.

2.3. Cell cultures
SaOS-2 cells were cultured in Dulbecco’s modified Eagle’s
medium with 10% fetal bovine serum, 2 mM glutamine, 1 ×
105 U L−1 penicillin and 0.1 mg l−1 streptomycin in a humidified incubator at 37°C and 5% CO2. Cells were harvested
with TriReagent after 5 days of culture and stored at −80°C
until RNA and protein extraction.

2.4. RNA extraction, quantification and quality
assessment
RNA extraction was performed immediately after bone homogenization. As detailed in figure 2, after homogenization,
tubes were kept in ice, in a vertical position for 5 min, to

2.5. Gene expression
Total RNA was submitted to digestion with DNase I (Invitrogen, ThermoFisher Scientific) to eliminate any potential DNA
contamination, and then reverse transcribed using the iScript
cDNA Synthesis Kit (Bio-Rad Laboratories). Reverse transciption quantitative polymerase chain reaction (RT-qPCR) was
performed on a QuantStudio 12 K Flex Real-Time PCR
System (Applied Biosystem, ThermoFisher Scientific), using
the TaqMan Gene Expression Master Mix and pre-made 6-carboxyfluorescein (FAM)-labelled TaqMan assay for sclerostin
(SOST, Hs00228830_m1), periostin (POSTN, Hs01566750_m1)
and osteopontin (SPP1, Hs00959010_m1) (ThermoFisher
Scientific). As potential reference genes, β-actin (ACTB,
Hs99999903_m1), glyceraldehyde 3-phosphate dehydrogenase
(GAPDH,
Hs99999905_m1) and rRNA 18S
(18S,
Hs99999901_s1) were tested. RT-qPCR was performed based
on the following protocol: polymerase activation for 2 min at
50°C, followed by a second step at 95°C for 10 min, 40 amplification cycles at 95°C for 15 s and 60°C for 60 s. Results were
reported as quantification cycle (Cq) values. The expression
stability of the potential reference genes was assessed
by considering the relative expression of these genes as the
difference between the Cq of a reference gene in a sample and
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Figure 1. Cortical and trabecular bone pieces. Fragments of cortical and trabecular bone were used in this experimental setting. The scale (ruler on the
left) is in centimetres.

allow the residual bone powder to sediment at the bottom of
the tube. The TriReagent supernatant was then transferred to
a 1.5 ml nuclease-free tube (1 ml of TriReagent in a 1.5 ml
tube), and RNA extraction was performed as recommended
by the TriReagent protocol (Ambion Inc., ThermoFisher Scientific, Waltham, MA, USA) (figure 2). Two hundred
microlitres of chloroform (Sigma, St Louis, MO, USA) (200 µl
chloroform per 1 ml TriReagent (1 : 5)) was added to each
sample. Tubes were manually shaken and, after 3 min at
room temperature and after being centrifuged at 12 000g for
15 min at 4°C to allow phase separation, the aqueous phase
was used for RNA extraction, while the phenol–ethanol
phase was used for protein extraction (see Protein extraction,
quantification and quality assessment). The aqueous phase
from each tube was transferred to a new tube, in which
500 µl of 100% isopropanol was added (500 µl per 1 ml TriReagent (1 : 2)). After inverting four times and resting at room
temperature for 10 min, tubes were centrifuged at 12 000g for
15 min at 4°C; the supernatant was discarded whereas the
pellet was washed three times in 75% ethanol for 5 min at
7500g at 4°C. After being dried, the pellet was resuspended
in nuclease-free water (15 µl for pellets derived from cortical
bone and 25 µl for pellets derived from trabecular bone).
The RNA concentration was quantified on a NanoDrop spectrophotometer (ThermoFisher Scientific). RNA purity was
assayed by assessing the 260/280 nm and 260/230 nm absorbance ratios (with optimal values >1.8) [13]. RNA integrity
was evaluated electrophoretically on 1% agarose gel and by
subsequently calculating the ratio of the intensity of the
bands relative to 28S and 18S rRNA [14]. The analysis of
the 28S and 18S peaks was performed using Image Lab 6.0 software (Bio-Rad Laboratories, Hercules, CA, USA). RNA
isolation from SaOS-2 cells was performed as recommended
by the TriReagent protocol (Ambion Inc.), and as previously
described, avoiding the homogenization step. RNA from
SaOS-2 cells was used as an internal control. After these quality
control checks, RNA samples were frozen at −80°C until gene
expression analysis.

royalsocietypublishing.org/journal/rsob
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cortical
bone

homogenization in
TriReagent
phase separation

100 mg ml–1,
shaking for 20 s (×7)

aqueous phase
(RNA)
interphase
(DNA)
organic phase
(protein)

RNA extraction

protein extraction

1. RNA precipitation with 500 l 100% isopropanol (10 min at RT,
then centrifugation at 12 000g for 15 min at 4°C)

1. DNA precipitation with 300 l 100% ethanol (3 min RT, then
centrifugation at 2000g for 5 min at 4°C)

2. RNA pellet washed three times in 75% ethanol for 5 min at 7500g
at 4°C

2. Protein precipitation with 2 ml 100% isopropanol (10 min at RT,
then centrifugation at 12 000g for 10 min at 4°C)

3. RNA pellet dried at RT for 30–40 min

3. Protein pellet washed three times in 2 ml 0.3 M guanidine
hydrochloride in 95% ethanol (20 min at RT, then centrifugation at
7500g for 5 min at 4°C)

4. RNA pellet resuspension in nuclease-free water (15 l for cortical
bone, 25 l for trabecular bone)
5. RNA quantification

4. Protein pellet washed with 2 ml 100% ethanol (20 min at RT
followed by centrifugation at 7500g for 5 min at 4°C)
5. Protein pellet dried for 10 min
6. Protein pellet solubilization in 300 l 1% SDS for 40 min at 50°C
7. Insoluble material removal by centrifugation three times at
10 000g for 10 min at 4°C

Figure 2. Experimental procedure applied for RNA and protein extraction from bone. Schematic representation of the workflow adopted for RNA and protein
extraction from cortical and trabecular bone. Specimens from both cortical and trabecular bone were ground into powder by mechanical degradation in liquid
nitrogen and then mechanically homogenized, using ceramic beads, in TRIzol reagent. After separation of the aqueous and the organic phases, containing, respectively, RNA and protein, two different protocols were carried out, as detailed in the figure. RT, room temperature; SDS, sodium dodecyl sulfate.
the geometrical mean of the Cq of ACTB, GAPDH and 18S in all
samples. The expression stability of these genes was analysed
using the NormFinder algorithms and GAPDH was found to
be the most stable one. The relative expression of SPP1,
POSTN and SOST was than calculated by the 2−ΔΔCq method,
using GAPDH as a reference gene.

2.6. Protein extraction, quantification and quality
assessment
Proteins were extracted from bone specimens (cortical and trabecular) and SaOS-2 cells following the TriReagent protocol
(Ambion Inc.) (figure 2). After phases separation, in order to
remove any aqueous phase overlying the interphase and
DNA contamination, 300 µl of 100% ethanol (300 µl ethanol
per 1 ml TriReagent (1 : 3.3)) was added to each tube, followed
by multiple tube inversions. After 3 min rest at room temperature, samples were centrifuged for 5 min at 2000g at 4°C and
the protein fraction-containing supernatants were collected in
new tubes and stored at −80°C, according to the manufacturer’s
instructions. Once thawed, the phenol–ethanol phases were
incubated with 1.5 ml of 100% isopropanol (1.5 ml
isopropanol per 1 ml TriReagent (1.5 : 1)), after inverting a few
times, for 10 min at room temperature; then the suspensions
were centrifuged for 10 min at 12 000g at 4°C. The obtained pellets were washed three times with 2 ml of 0.3 M guanidine
hydrochloride in 95% ethanol (2 ml guanidine hydrochloride
0.3 M in 95% ethanol per 1 ml TriReagent (2 : 1)), left to incubate
for 20 min at room temperature and then centrifuged for 5 min

at 7500g at 4°C. Pellets were washed in 2 ml of 100% ethanol, left
to incubate for 20 min at room temperature and then centrifuged for 5 min at 7500g at 4°C. Protein pellets were left to
rest for 10 min at room temperature to dry; thereafter, pellets
were resuspended in 300 µl (pellets from bone specimens) and
70 µl (pellets from SaOS-2 cells) of 1% sodium dodecyl sulfate
(SDS) and incubated for 40 min at 50°C. Suspensions were centrifuged three times for 10 min each at 10 000g at 4°C in order to
remove insoluble materials. Between each centrifugation, the
supernatants were transferred to new tubes. The supernatant
obtained from the final centrifugation was stored at −80°C. Proteins were quantified using a Pierce BCA Protein Assay Kit
(ThermoFisher Scientific) and the absorbance was measured
with a Victor multilabel plate reader (Perkin Elmer, Waltham,
MA, USA) at λ = 540 nm. The protein concentration was determined from interpolation of the absorbance reading on a
linear regression standard curve. Bio-Safe Coomassie Staining
(Bio-Rad Laboratories) was used to assess the protein integrity
with 12% sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE). For staining, gels were incubated for
1 h with Bio-Safe Coomassie Staining and then washed with distilled water overnight at room temperature.

2.7. Western blotting
Ten micrograms of extracted proteins were separated on 12%
SDS-PAGE. Proteins were then transferred onto a polyvinylidene fluoride (PVDF) membrane (Bio-Rad Laboratories) and
activated in methanol for 30 s. After blocking with 5% not-fat

Open Biol. 12: 210387
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Statistical analysis was performed with Prism® v. 6.01
(GraphPad Software Inc., La Jolla, CA, USA). The normal distribution of data was tested through the D’Agostino Pearson
normality test. Comparison of gene and protein expression
between cortical and trabecular bone was performed through
the Mann–Witney test. Differences were considered to
be statistically significant if p-values were <0.05.

3. Results
3.1. RNA quantity, quality and integrity
Total RNA was isolated from cortical and trabecular bone
(figure 1). As a control for RNA isolation using a standard protocol without homogenization, total RNA was extracted from cells
(SaOS-2). Total RNA concentrations are shown in table 1. The
yield from trabecular bone (1639.08 ± 414.86 ng µl−1) was
higher than that from cortical bone (731.86 ± 418.91 ng µl−1).
RNA purity, i.e. samples free from protein and organic compound contaminations, was determined spectrophotometrically
by means of the 260/280 nm and 260/230 nm absorbance
ratios. As shown in table 1, ratios greater than or equal to 1.8, in
most samples, similar to those obtained for RNA extracted
from SaOS-2 cells, indicate a high-quality level of RNA; in only
five samples the 260/230 nm ratio was lower, but very close to
1.8. To assess RNA integrity, intact 28S and 18S rRNA was
assayed on agarose gel electrophoresis (figure 3 and electronic
supplementary material, figure S1) by calculating the 28S/18S
band intensity ratio (table 1). The readings revealed no degradation signs and intact RNA in all samples. The mean ± s.d. of
the 28S/18S intensity ratios was 1.68 ± 0.35, 1.88 ± 0.10 and
2.00 ± 0.02 for cortical bone, trabecular bone and SaOS-2 cells,
respectively.
Table 1 shows the value of the RNA concentration (ng µl−1),
RNA (ng) per unit of tissue weight (100 mg), 260/280 nm and
260/230 nm absorbance ratios measured using a NanoDrop

sample

ng µl−1 ng/100 mg 260/280

260/230 28S/18S

SaOS-2 a 1318.05
SaOS-2 b 931.33

/
/

1.98
1.96

1.91
1.98

1.98
2.02

1c
1t

727.07
1257.39

10 906.05
31 434.75

1.95
1.96

2.01
2.09

1.62
1.96

2c

477.18

7157.70

1.93

1.82

1.69

2t
3c

1244.57
595.48

31 114.25
8932.20

1.95
1.96

2.20
1.93

1.89
1.61

3t
4c

1251.89
675.23

31 297.25
10 128.45

1.93
2.02

2.07
1.99

1.85
1.39

4t
5c

1734.36
567.18

43 359.00
8507.70

1.97
1.98

2.02
1.80

1.88
1.50

5t

1766.33

44 158.25

1.98

1.97

1.93

6c
6t

609.76
1891.87

9146.40
47 296.75

1.92
1.98

1.67
1.76

1.60
1.64

7c
7t

1884.21
2344.07

28 263.15
58 601.75

1.95
1.96

1.78
1.70

2.63
1.82

8c

384.62

5769.30

1.87

1.81

1.54

8t
9c

1143.34
702.04

28 583.50
10 530.60

1.97
2.03

1.81
2.06

1.91
1.53

9t
10c

1603.53
695.79

40 088.25
10 436.85

1.97
2.03

2.30
1.77

1.98
1.56

10t

2153.44

53 836.00

1.97

2.12

1.94

spectrophotometer (ThermoFisher Scientific, Waltham, MA,
USA) and the 28S/18S ribosomal RNA ratio using Image Lab
6.0 software (Bio-Rad Laboratories, Hercules, CA, USA). As
an index of RNA purity, the 260/280 nm and 260/230 nm
absorbance ratios were used; as an index of RNA integrity,
the 28S/18S ribosomal RNA ratio was used.

3.2. Gene expression analysis in cortical and trabecular
bone
To test the applicability of the isolated RNA in downstream
molecular biology analyses, the expression of bone-specific
genes was analysed through RT-qPCR. Cq values of genes
encoding for SPP1, SOST, POSTN, ACTB, GAPDH and 18S
are shown in table 2.
ACTB, GAPDH and 18S were tested as reference genes. The
expression level of these genes, in term of ΔCq, revealed that the
distribution width of the GAPDH level was more strict than
those of ACTB and 18S considering cortical and trabecular
bone samples, both separately and matched (figure 4).
Moreover, according to the NormFinder analysis, GAPDH
was the most reliable reference gene in this specific experimental setting (GAPDH s.d. = 0.67; ACTB and 18S s.d. > 1).
Gene expression analysis highlighted relevant differences
between cortical and trabecular bone with SPP1, SOST
and POSTN being more expressed in the cortical than in
the trabecular fraction (figure 5).

5
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2.8. Statistical analysis

Table 1. Concentration, quality and integrity of cortical and trabecular
bone RNA.

royalsocietypublishing.org/journal/rsob

dried milk or 5% bovine serum albumin in 0.1% Tris-buffered
saline with 0.1% Tween® 20 detergent, for 1 h at room temperature, membranes were incubated overnight at 4°C with with
anti-sclerostin (SOST) (AP13236PU-N) (Origene, Rockville,
MD, USA), anti-osteopontin (OPN) (ab8448; RRID:
AB_306566) (Abcam, Cambridge, UK), anti-osteonectin
(SPARC) (cs5420; RRID: AB_10692794) (Cell Signaling,
Danvers, MA, USA), anti-osteocalcin (OCN) (ab133612)
(Abcam, Cambridge, UK), anti-vinculin (ab129002; RRID:
AB_11144129) (Abcam), anti-β-actin (TA811000) (Origene) or
anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(ab9485; RRID: AB_307275) (Abcam) antibody. After incubation
with secondary antibodies, goat anti-mouse immunglobulin G
(IgG) (H + L)-horseradish peroxidase (HRP) conjugate (170–
6516; RRID: AB_11125547) and goat anti-rabbit IgG (H + L)HRP conjugate (170–6515; RRID: AB_11125142) (Bio-Rad Laboratories) for 1 h at room temperature, protein detection was
performed using Clarity-Max Enhanced Chemioluminescence
(ECL) (Bio-Rad Laboratories). Signals were detected with
ChemiDoc (Bio-Rad Laboratories). To test the best loading
control for protein analysis, i.e. the one with the lowest variability, the coefficients of variation (CoV) of the densitometry values
for β-actin, GAPDH and vinculin were compared.

1T

2C

2T

3C

3T

4C

4T

5C

SaOS-2

6C

6T

7C

7T

8C

8T

9C

9T

10C 10T

6

5T

Figure 3. RNA from SaOS-2 cells and cortical and trabecular bone. Agarose gel (1%) of RNA isolated from SaOS-2 cells and cortical (C) and trabecular (T) bone.
Table 2. Quantiﬁcation cycle (Cq) values of ACTB, GAPDH, 18S, SOST, POSTN and SPP1 of SaOS-2 cells and cortical and trabecular bone from gene expression
analyses through RT-qPCR. c, cortical bone; t, trabecular bone; ACTB, β-actin; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; 18S, 18S ribosomal RNA; SOST,
sclerostin; POSTN, periostin; SPP1, osteopontin.
sample

ACTB

GAPDH

18S

SOST

POSTN

SPP1

SaOS-2 a

31.70

29.29

24.10

37.43

37.81

34.32

SaOS-2 b
1c

30.15
>38

28.01
34.76

24.52
32.73

36.41
>38

35.80
35.96

32.85
27.66

1t

35.32

32.23

30.26

>38

34.62

27.97

2c
2t

>38
36.57

35.44
32.39

32.57
30.68

>38
>38

36.53
35.05

27.63
28.25

3c
3t

>38
35.16

35.04
31.70

32.42
27.25

>38
>38

34.75
33.94

27.26
28.42

4c

37.56

33.03

28.65

36.14

32.76

26.83

4t
5c

29.42
37.72

28.48
33.67

23.72
25.12

>38
35.71

32.33
30.27

26.86
24.09

5t
6c

36.65
34.68

33.04
32.12

27.90
27.81

>38
36.50

34.54
32.15

28.02
23.91

6t
7c

33.71
34.32

32.09
31.48

27.79
27.94

>38
>38

33.80
31.43

25.97
24.15

7t

35.40

33.67

30.20

>38

28.59

27.95

8c
8t

34.54
33.43

32.48
30.51

28.75
27.17

36.40
>38

30.68
34.37

23.10
27.68

9c
9t

>38
31.16

33.38
29.39

29.64
24.16

36.85
>38

32.51
33.43

27.13
27.17

10c

37.03

32.80

28.35

36.32

32.64

26.46

10t

30.76

29.52

24.00

>38

33.21

27.34

3.3. Protein quantity, quality and integrity
Proteins were extracted from cortical and trabecular bone and
from SaOS-2 cells as a control.
The mean values of the cortical and trabecular bone
protein concentrations were 1301.12 ± 589.93 ng µl−1 and
1067.15 ± 339.82 ng µl−1, respectively (table 3).

Table 3 shows the protein concentration values in micrograms per millilitre and micrograms of protein per unit of
tissue weight (100 mg) of both cortical and trabecular bone.
The concentration (μg ml−1) of proteins extracted from
SaOS-2 cells is also reported.
Staining with Coomassie blue has not revealed any degradation in proteins obtained after bone homogenization, as in
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Figure 4. Expression profile of ACTB, GAPDH and 18S in cortical and trabecular bone. Relative expression of ACTB, GAPDH and 18S in cortical bone samples (a),
trabecular bone samples (b) and both cortical and trabecular samples (c). The relative expression for each gene is calculated as the difference between the Cq of a
reference gene in a sample and the geometrical mean of the Cq of ACTB, GAPDH and 18S of all samples. Data are shown as the 5th–95th percentiles.
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Figure 5. SPP1, SOST and POSTN expression levels in cortical and trabecular bone. Expression profiles of SPP1, SOST and POSTN in cortical and trabecular bone.
Statistical analyses of the expression profiles in cortical and trabecular bone were performed through the Mann–Whitney test. p-value < 0.05 indicates a statistically
significant comparison. All data are shown as the 5th–95th percentiles. Statistical analysis was performed with Prism v. 6.01 (GraphPad Software).
Table 3. Concentration of SaOS-2 cells and cortical and trabecular bone proteins.
μg ml−1
sample
SaOS-2
1

cortical bone

μg/100 mg
trabecular bone

cortical bone

trabecular bone

1051.30
791.89

1240.04

237 567

372 012

2
3

1306.89
1154.19

759.80
767.91

392 067
346 257

227 940
230 373

4

1489.35

1805.23

446 805

541 569

5
6

2200.75
443.74

1173.39
1137.97

660 225
133 122

352 017
341 391

7
8

1398.65
376.63

1332.69
885.77

419 595
112 989

399 807
265 731

9
10

2306.05
895.00

762.63
806.07

691 815
268 500

228 789
241 821

SaOS-2 cells (figure 6 and electronic supplementary material,
figure S2). Importantly, the staining has highlighted a
different protein pattern between cortical and trabecular bone
(figure 6 and electronic supplementary material, figure S2).

3.4. Expression of cortical and trabecular bone proteins
β-actin, GAPDH and vinculin were tested as potential loading control for cortical and trabecular bone proteins. As
shown in figure 7 and electronic supplementary material,

figure S3, β-actin had the lowest variability among all the
analysed samples: the distribution of densitometry values
of GAPDH and vinculin was much more scattered than the
distribution of β-actin, considering all samples together.
This result was confirmed by the CoV of densitometry
values, as shown in table 4. The CoV of actin (0.27)
were significantly lower than those of GAPDH (1.02) and vinculin (0.98).
Expression of bone-specific proteins such as OPN, SPARC,
OC and SOST was assayed in both cortical and trabecular bone

Open Biol. 12: 210387

SPP1

royalsocietypublishing.org/journal/rsob

10

SaOS-2

1C

2C

3C

4C

1T

2T

3T

4T

Downloaded from https://royalsocietypublishing.org/ on 31 May 2022

4. Discussion
Improving the methods for total RNA and protein extraction
from human bone could enhance the potential of studies
aimed at understanding relevant aspects of bone biology,
and contribute to the discovery and validation of reliable biomarkers of bone disease. Being a mineralized tissue, which
is very difficult to handle, molecular analysis of human
bone is more challenging than the corresponding analysis
in soft tissues [15]. Indeed, current studies on RNA and
protein extraction from bone are mainly focused on experimental animal models (e.g. mice, rats), which are easier to
handle, rather than on human bone [2,8,16–18]. Studies
using TRIzol-based protocols to extract proteins are more
common in the case of soft tissues or cell lines [12,19–21];
moreover, protein extraction methods were mainly propaedeutic to proteomic analysis that is based, principally, on
bone decalcification followed by protein solubilization and,
hence, do not rely on the analysis of native proteins [22–25].
In this study, we describe a TRIzol-based total RNA and
protein extraction method from both human cortical and trabecular bone. This is a multistep approach that starts with
bone pulverization and homogenization with beads followed
by total RNA and protein extraction, from the same sample.
The requirement of the pulverization step is fundamental in
RNA isolation from tissue as hard as bone to isolate highquality RNA, as has been demonstrated in a study by
Wilson et al. [15]. The coupled extraction of total RNA and
protein represents another crucial step in molecular analysis
and optimizes the yield in cases of small samples or in
cases of limited availability of surgical samples. Moreover,
the possibility to extract RNA and proteins from the same
sample enables a direct and parallel comparison between
transcriptome and proteome for a better understanding of
the molecular mechanisms underlying the pathogenesis of
bone diseases. Although studies have detailed the extraction
of RNA or proteins from bone using TRIzol reagent, our current report represents the first one describing a strategy for
the simultaneous extraction of both molecules from human
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(figure 8 and electronic supplementary material, figures S4–
S6). While no differences were observed for SOST and OPN,
the expression of OC and SPARC was higher in cortical bone
than in trabecular bone.
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Figure 6. Protein profile of SaOS-2 cells and cortical and trabecular bone. Coomassie blue staining of protein extracted from SaOS-2 cells and cortical (C) and
trabecular (T) bone. For each sample, 10 ng of protein was separated on 12%
acrylamide gel.

bone. This study also evaluated the application of this strategy to the two fractions, cortical and trabecular, obtained
from the same carrot, highlighting the potential of assessing
molecular differences in these two compartments. These
measures may improve the results detailed in previous
studies, as in Piccoli et al. [26]. This study detailed whether
the alteration of sclerostin gene expression and of accumulation of advanced glycation end-product (AGE) can affect
bone turnover and fracture risk in patients with type 2 diabetes (T2D). The analysis on bone formation and
Wnt pathway markers, together with the analyses on bone
microarchitecture and strength, were performed on trabecular bone of postmenopausal women with or without
T2D who were undergoing hip replacement surgery. Results
showed a decrease in gene expression of the bone-forming
transcription factor RUNX2 and an increase in sclerostin
gene expression in patients with T2D. The assessment of
these bone markers also in cortical bone, besides highlighting
differences in the two bone compartments, would provide
new insights into bone fracture risk in patients with T2D [26].
The main challenge in performing molecular analysis on
RNA and protein is represented by the preservation of their
integrity and, indeed, our first goal was to avoid any degradation. Because of this, each step was performed at
temperatures near freezing: bone pulverization was conducted
in liquid nitrogen and bone homogenization was performed
using pre-chilled materials and leaving samples for 1 min in
ice between each homogenization cycle. To assess the RNA
integrity, the 28S and 18S rRNA bands on agarose gel were analysed and the 28S/18S intensity ratio was calculated for all
samples. The ratio values obtained for cortical (1.68 ± 0.35)
and trabecular (1.88 ± 0.10) bone tended to the optimal value,
i.e. 2 [11]. It is noteworthy that the 28S/18S ratio for cortical
bone tended to be lower than that for trabecular bone, probably
because cortical bone is harder to pulverize and homogenize
than trabecular bone. As shown by our results, the
measures adopted in our multistep extraction protocol allowed
us to obtain high-quality RNA. This is in contrast with the
results from Carter et al. [8], who pointed out the importance
of performing mouse bone pulverization and RNA extraction
in a single step [8]. RNA integrity can also be ensured
by storing samples in an RNA stabilization reagent such as
RNAlater. A recent study by Pedersen et al. [17] has demonstrated that incubation of mouse bone (femur shaft, femur
bone marrow and vertebral bone) with RNAlater improves
RNA quality [17]. However, although we did not have a comparison with an RNAlater-stored counterpart, our results
revealed that extracting intact RNA without the use of any
RNA stabilization reagents is possible and reliable.
To assess protein integrity, Coomassie blue staining of total
protein extracts following SDS-PAGE was performed and, as
for RNA, the distribution patterns of bands revealed protein
integrity in both the cortical and the trabecular compartments.
These results suggest that bead-based bone homogenization
can be effectively applied to extract RNA and proteins that
are qualitatively comparable to those obtained from SaOS-2
cells, where no homogenization step is required.
Besides RNA integrity, an assessment of RNA purity is
also needed to perform gene expression analysis and a
highly pure material is required to obtain meaningful and
reliable results. Indeed, contamination due to phenolic compounds, used during the extraction process, or proteins
could interfere with the downstream RT-qPCR-based
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Figure 7. Expression profile of loading control protein β-actin, GAPDH and vinculin in SaOS-2 cells and cortical and trabecular bone. (a) Immunoblot analysis of
expression levels of loading control protein β-actin, GAPDH and vinculin in SaOS-2 cells and cortical and trabecular bone. (b) Densitometry analysis of β-actin,
GAPDH and vinculin in SaOS-2 cells and cortical (C) and trabecular (T) bone. Data are shown as the 5th–95th percentiles.
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Figure 8. Expression profiles of OPN, sclerostin, OC and SPARC in SaOS-2 cells and cortical and trabecular bone. (a) Immunoblot analysis of expression levels of OPN,
sclerostin, OC and SPARC in SaOS-2 cells and cortical (C) and trabecular (T) bone. (b) Densitometry analysis of OPN, sclerostin, OC and SPARC in SaOS-2 cells and
cortical and trabecular bone. Data are shown as the 5th–95th percentiles. Statistical analysis of expression profiles in cortical and trabecular bone were performed
through the Mann–Whitney test. p-value < 0.05 indicates statistically significant comparison. All data are shown as the 5th–95th percentiles. Statistical analysis was
performed with Prism v. 6.01 (GraphPad Software).
applications, compromising experimental results [13]. The
spectrophotometric assessment of RNA purity by the ratio
of the optical readings at 260/280 nm, to verify protein contamination, and at 260/230 nm, to verify contamination by
phenolic compounds or any other reagents used during the
extraction process, has shown values >1.8, indicating the
purity of the extracted RNA. Thereby, the RNA obtained
with this method was intact, free of protein and organic compound contamination and free of genomic DNA, owing to
the applied step of treatment with DNase. Thus, all the factors potentially affecting downstream analyses were
virtually eliminated. As a matter of fact, we successfully analysed the expression of bone-specific genes (i.e. SPP1, SOST

and POSTN) by RT-qPCR and relevant differences were highlighted between the two fractions.
Related to TRIzol-based protein extraction, protein pellet
solubilization represents the main challenge, since, following
this method, a packed protein pellet is produced. A non-complete solubilization could alter the correct protein estimation
and may represent a limitation for downstream analysis.
Indeed, several studies described alternative methods for
protein solubilization in order to improve the yield [12,19,21].
In our study, protein solubilization was performed according to the TRIzol manufacturer’s protocol, by suspending
protein pellets in 1% SDS and by incubating pellets for
40 min at 50°C.
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Table 4. Protein expression stability of β-actin, GAPDH and vinculin.

cortical
bone

trabecular
bone

cortical and
trabecular bone

β-actin

0.21

0.29

0.27

GAPDH
vinculin

1.03
0.75

1.07
0.98

1.02
0.98
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Protein of both high and low molecular weight was successfully extracted from both cortical and trabecular bone
and proteins from the two compartments had consistently
different distribution patterns. Immunoblotting analyses for
some of the bone-specific proteins, such as OPN, SPARC,
total OC and sclerostin, confirmed the stability and the maintenance of immune reactivity of the extracted proteins and
confirmed the existence of a different expression profile in
different bone compartments. Despite the reliability and the
high quality and yield of total RNA and proteins obtained
with this method, this study suffers from some limitations.
The main one is the lack of comparison with other methods.
Working with human samples suffers from limited availability of withdrawable specimens and their small size;
therefore, the possibility of processing the same sample
with different methods is, actually, limited. Moreover, in
this study, long-term RNA and protein stability has not
been investigated. This would represent another limit of the
study as well as the lack of analysis of low expression/less
stable proteins, high molecular weight proteins, membranebound proteins and those with a tendency to aggregate.
Further studies would be needed to define whether storage
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